Key Points Recent research challenges the belief that antidepressants must always be stopped before psychedelic therapy. A 2025 scoping review suggests that combining antidepressants with classic psychedelics, particularly psilocybin, is generally safe and tolerable. The risk of serotonin syndrome appears to be low. Current research...
Could non-hallucinogenic compounds derived from psychedelics be the next frontier in anti-inflammatory medicine? Researchers are exploring a new class of drugs, called PIPIs (Psychedelic drug Informed but Psychedelic-experience Inactive), which are derived from psychedelics but do not cause hallucinations. These compounds show promise in treating...
Can psychedelics help treat addiction by rebalancing brain chemistry? A review of recent studies suggests that psychedelics, particularly psilocybin, may help treat substance use disorders by balancing dopamine levels in the brain, which can reduce cravings and the risk of relapse. This article will delve...
Can ayahuasca-assisted therapy help people cope with prolonged grief after losing a loved one? A recent study has shown that ayahuasca-assisted meaning reconstruction therapy can significantly help individuals struggling with prolonged grief disorder. This article will examine the study's findings, how ayahuasca facilitates the grieving...